Fortitude Family Office, LLC
Family OfficePosition in BIIB — Biogen Inc.
CIK 1950506
SCOTTSDALE, AZ
Position in BIIB
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$68,058
+$55,409 QoQ
Shares Held
315
+356.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#815
of 1,031 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $6,252,480 across 11 Drug Manufacturers - General names. BIIB ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,046 | $3,653,464 | |
| 2 | ABBV |
AbbVie Inc.
|
4,225 | $1,063,179 | |
| 3 | JNJ |
Johnson & Johnson
|
1,844 | $468,320 | |
| 4 | AMGN |
Amgen Inc
|
1,172 | $424,404 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,950 | $379,075 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
690 | $87,174 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,205 | $69,432 | |
| 8 | BIIB |
Biogen Inc.
This page
|
315 | $68,058 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,058 | 315 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $12,649 | 69 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,631 | 32 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,801 | 20 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,511 | 20 | Shares | Sole | 2025-07-15 | |
| 2024-09-30 | $2,326 | 12 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,781 | 12 | Shares | Sole | 2024-07-10 | |
| 2023-12-31 | $1,811 | 7 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||